Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

The Reasons We Get Colorectal Cancer and Why It’s So Common

James Church

Colorectal Cancer Epidemiology and Screening in 2025

UCSF School of Medicine

S. Gupta

Early-Onset CRC: Epidemiology, Risk Factors, and Clinical Presentati…

Ibrahim Sahin

The Role of Microbiome in Colorectal Cancer

Benjamin Weinberg

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

48 Hours in the Life of Receiving a Diagnostic Colonoscopy

UCI Health

A. Dua

Colorectal Cancer Care Initiative (CRCCI)

Richard Goldberg

Pancreatic Cysts - Guidelines Based Management

AdventHealth

V. Shami

How Recent Data Impacts Pancreatic Cancer Management

Integrity CE

M. Pishvaian

Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…

UNC Lineberger Comprehensive Cancer Center

N. Robertson

ESMO 2024 Summary: Updates in Pancreatic Cancer and Impacts on Pract…

2024 ESMO Annual Meeting Insights Hub

H. Babiker

FDA Approval of Zenocutuzumab for Advanced NRG1 Fusion-Positive NSCL…

Memorial Sloan Kettering Cancer Center

A. Schram

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

Treating GI Cancers With Limited Resources

OncoAlert

N. Rashad

Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: …

Yale Cancer Center

M. Cecchini

Rising Trends of Colorectal Cancer Among Millennials

Dr. Iris Gorfinkel

I. Gorfinkel

ASCO® GI 2025 Insights: Real-World Evidence of Nanoliposomal Irinote…

Insights from 2025 ASCO® GI Annual Meeting

T. Shirakawa

ASCO® GI 2025 Insights: Trifluridine/Tipiracil vs. Placebo in Patien…

Insights from 2025 ASCO® GI Annual Meeting

H. Bando

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde